<section><div class="Schedule"><header><h2 class="scheduleLabel" id="h-3.141516"><span class="scheduleLabel">SCHEDULE VI</span><span class="OriginatingRef">(Sections 2, 6, 55 and 60)</span></h2></header><ul class="ProvisionList"><li><p class="indent-0-1"><span class="lawlabel">1</span> Benzyl methyl ketone (P2P) (1–phenyl–2–propanone)</p></li><li><p class="indent-0-1"><span class="lawlabel">2</span> Ephedrine (l–erythro–2–(methylamino)–1–phenylpropan–1–ol)</p></li><li><p class="indent-0-1"><span class="lawlabel">3</span> Ergometrine (9,10–didehydro–N–(2–hydroxy–1–methylethyl)–6–methylergoline–8–carboxamide)</p></li><li><p class="indent-0-1"><span class="lawlabel">4</span> Ergotamine (12'–hydroxy–2'–methyl–5'–(phenylmethyl) ergotaman–3',6',18–trione)</p></li><li><p class="indent-0-1"><span class="lawlabel">5</span> Lysergic acid (9,10–didehydro–6–methylergoline–8–carboxylic acid)</p></li><li><p class="indent-0-1"><span class="lawlabel">6</span> Pseudoephedrine (d–threo–2–(methylamino)–1–phenylpropan–1–ol)</p></li></ul></div></section>